No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity
暂无分享,去创建一个
S. Kutsuna | N. Ohmagari | I. Hamaguchi | Mio Endo | K. Okuma | E. Ikebe | M. Terada | S. Saito | Madoka Kuramitsu | K. Tezuka | N. Kinoshita | Tetsuya Suzuki | T. Nakamoto | Y. Miyazato | H. Nomoto | M. Inada
[1] S. Boyd,et al. SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution , 2020, Annals of Internal Medicine.
[2] L. Ren,et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. , 2020, JAMA.
[3] S. W. Long,et al. Treatment of COVID-19 Patients with Convalescent Plasma , 2020, The American Journal of Pathology.
[4] K. Rajendran,et al. Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review , 2020, Journal of medical virology.
[5] J. Zehnder,et al. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease , 2020, medRxiv.
[6] Lan Wang,et al. Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations , 2020, Emerging infectious diseases.
[7] So‐Yong Kwon,et al. Post‐donation COVID‐19 identification in blood donors , 2020, Vox sanguinis.
[8] Arturo Casadevall,et al. The convalescent sera option for containing COVID-19. , 2020, The Journal of clinical investigation.
[9] Fumihiro Kato,et al. Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan. , 2020, Japanese journal of infectious diseases.